Atlas Trials

PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)

Clinical trial NCT02074436 · TERMINATED

Trial details

NCT number
NCT02074436
Sponsor
Emory University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hematological MalignanciesThrombocytopenia
Start date
2014-05-23
Primary completion
2020-11-24
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.